balaji amines seems to be a good candidate for bottoming out.
the demand from the pharma and api side seems to be picking up (according to the latest concall).
new expansions are going to come online starting from this year for the next 2-3 years, the capacities coming up this year are better margin compared to the current product profile.
balaji specialty, the subsidiary has significantly higher margins than balaji amines, planning to introduce new products (first time products in india).
technically seems to have formed a bottom, waiting for further technical proof.
| Subscribe To Our Free Newsletter |
